Structure of Formononetin
CAS No.: 485-72-3
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Formononetin can act as an agonist of aryl hydrocarbon receptor (EC50 = 130 nM) and has prevention of breast cancer, prostate cancer and colon cancer. Formononetin could be extracted from the bark of Ononis natrix L..
Synonyms: Biochanin B; Flavosil; Formononetol Formononetin
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 485-72-3 |
| Formula : | C16H12O4 |
| M.W : | 268.26 |
| SMILES Code : | O=C1C(C2=CC=C(OC)C=C2)=COC3=C1C=CC(O)=C3 |
| Synonyms : |
Biochanin B; Flavosil; Formononetol Formononetin
|
| MDL No. : | MFCD00016948 |
| InChI Key : | HKQYGTCOTHHOMP-UHFFFAOYSA-N |
| Pubchem ID : | 5280378 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H315-H319-H335 |
| Precautionary Statements: | P261-P305+P351+P338 |
In Vitro:
|
Cell Line
|
Concentration | Treated Time | Description | References |
| HCC827 OR | 10μM | 24 hours | Formononetin significantly inhibited the cell viability of HCC827 OR cells. | J Exp Clin Cancer Res. 2020 Apr 10;39(1):62. |
| H1299 | 10μM | 24 hours | Formononetin significantly inhibited the cell viability of H1299 cells. | J Exp Clin Cancer Res. 2020 Apr 10;39(1):62. |
| A549 | 10μM | 24 hours | Formononetin significantly inhibited the cell viability of A549 cells. | J Exp Clin Cancer Res. 2020 Apr 10;39(1):62. |
| H1975 | 10μM | 24 hours | Formononetin significantly inhibited the cell viability of H1975 cells. | J Exp Clin Cancer Res. 2020 Apr 10;39(1):62. |
| H3255 | 10μM | 24 hours | Formononetin significantly inhibited the cell viability of H3255 cells. | J Exp Clin Cancer Res. 2020 Apr 10;39(1):62. |
| Human umbilical vein endothelial cells | 10 μM | 24 hours | FN stabilizes NRF2 levels in HUVECs, protecting cells from oxaliplatin-induced damage. | Redox Biol. 2020 Sep;36:101677. |
| Mouse dorsal root ganglion neurons | 10 μM | 24 hours | FN protects DRG neurons from oxaliplatin-induced damage by activating the NRF2-GSTP1 axis. | Redox Biol. 2020 Sep;36:101677. |
| ND7/23 neuron cells | 10 μM | 24 hours | FN protects neurons from oxaliplatin-induced damage by activating the NRF2 pathway, increasing NRF2 protein levels and reducing ROS production. | Redox Biol. 2020 Sep;36:101677. |
| BUMPT cells | 25 mg/kg | 3 days | Induced PRDM16 expression, peaking at 25 mg kg−1 | Adv Sci (Weinh). 2024 Feb;11(7):e2306704. |
| Human aortic smooth muscle cells (HASMCs) | 1-5 μM | 24 hours | Inhibited oxLDL-induced foam cell formation and reduced lipid droplet accumulation | Theranostics. 2020 Jan 1;10(3):1090-1106. |
| Peritoneal macrophages (PMs) | 1-5 μM | 24 hours | Inhibited oxLDL-induced foam cell formation and reduced lipid droplet accumulation | Theranostics. 2020 Jan 1;10(3):1090-1106. |
| Hep3B cells | 20μM, 40μM | Formononetin treatment inhibited the binding of SLUG to the promoter of E-cadherin, upregulated the expression level of epithelial markers (E-cadherin, cytokeratin, and occludin), and downregulated the expression level of mesenchymal markers (Vimentin, N-cadherin, and myosin). | Theranostics. 2019 Jan 1;9(2):573-587. | |
| PLC-PRF-5 cells | 20μM, 40μM | Formononetin treatment inhibited the binding of SLUG to the promoter of E-cadherin, upregulated the expression level of epithelial markers (E-cadherin, cytokeratin, and occludin), and downregulated the expression level of mesenchymal markers (Vimentin, N-cadherin, and myosin). | Theranostics. 2019 Jan 1;9(2):573-587. | |
| BUMPT cells | 20 µM | 30 minutes | Formononetin significantly reduced I/R-stimulated BUMPT cell apoptosis and inhibited the activation of p38MAPK and JNK by upregulating the PRDM16/S100A6/PKC-η/ROS signaling pathways. | MedComm (2020). 2024 Sep 21;5(10):e737. |
In Vivo:
|
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
| Nude mice | Xenograft model | Intraperitoneal injection | 10 mg/kg | Once daily until the endpoint of the experiment | Formononetin significantly inhibited the growth of xenograft tumors, including HCC827, H3255, H1975, A549, and H1299-derived tumors. | J Exp Clin Cancer Res. 2020 Apr 10;39(1):62. |
| C57BL/6 male mice | Oxaliplatin-induced peripheral neuropathy model | Intraperitoneal injection | 10.0 mg/kg | Daily injections for two cycles (5 days of injection and 5 days of rest per cycle) | FN alleviates mechanical and cold sensitivity in mice by activating the NRF2 signaling pathway and reduces morphological damage in DRG neurons. | Redox Biol. 2020 Sep;36:101677. |
| ApoE-deficient mice | High-fat diet-induced atherosclerosis model | Oral | 10 mg/kg/day | Once daily for 16 weeks | Formononetin significantly reduced atherosclerotic lesion size, enhanced plaque stability, reduced macrophage accumulation and calcification | Theranostics. 2020 Jan 1;10(3):1090-1106. |
| Db/db diabetic mice | Diabetic kidney disease model | Intragastric administration | 25 mg/kg | Once a day for four weeks | Attenuated renal fibrosis, MAPK activation, and TGF-β1 expression | Adv Sci (Weinh). 2024 Feb;11(7):e2306704. |
| Nude mice | Hepatocellular carcinoma xenograft model | Subcutaneous injection | 100 mg/kg | Every 2 days for 15 days | Formononetin treatment inhibited tumor volume, fluorescence intensity, tumor weight, and the formation of pulmonary metastatic nodules. IHC analysis showed that Formononetin treatment decreased the expression of SLUG, Vimentin, and Ki67, and increased the expression of E-cadherin. | Theranostics. 2019 Jan 1;9(2):573-587. |
| C57BL/6J mice | Cecal ligation and puncture (CLP)-induced sepsis model | Tail vein injection | 20 mg/kg | Single dose, observed for 18 hours | To evaluate the protective effect of Formononetin/PLGA on sepsis-induced multi-organ injury. Results showed that Formononetin/PLGA inhibited ferroptosis by upregulating the PRDM16/NRF2/GPX4 axis, alleviating sepsis-induced kidney injury and other organ injuries. | Redox Biol. 2024 Dec;78:103417. |
| Mice | Ischemia/reperfusion (I/R) and cisplatin-induced acute kidney injury (AKI) model | Oral administration | 25 mg/kg | 3 consecutive days | Formononetin significantly ameliorated the progression of I/R- and cisplatin-triggered AKI in mice by regulating the PRDM16/S100A6/PKC-η/ROS/p38MAPK and JNK axes. | MedComm (2020). 2024 Sep 21;5(10):e737. |
Clinical Trial:
| NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
| NCT02174666 | Osteopenia Os... More >>teoporosis Less << | Not Applicable | Unknown | September 2016 | Denmark ... More >> Aarhus University Hospital Aarhus, Central Jutland Region, Denmark, 8000 Less << |
| NCT01497977 | Low Serum Lipid Levels | Phase 4 | Completed | - | Serbia ... More >> Ultramedica Clinic, American Medical Academy Belgrade, Serbia, 11000 Less << |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.73mL 0.75mL 0.37mL |
18.64mL 3.73mL 1.86mL |
37.28mL 7.46mL 3.73mL |
|
Tags: Formononetin | Biochanin B | Flavosil | Formononetol | FGFR2 inhibitor | fibroblast growth factor receptor 2 | tumor growth | angiogenesis | FGFR | Apoptosis | Fibroblast growth factor receptor | Anti-angiogenic | anti-cancer | angiogenesis | FGFR2 | Akt | 485-72-3
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


